Verona pharma to report third quarter 2022 financial results and provide corporate update

London and raleigh, n.c., oct. 26, 2022 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma” or the “company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the third quarter ended september 30, 2022 on wednesday, november 9, 2022 and host an investment community conference call at 9:00 a.m. est / 2:00 p.m. gmt to discuss these financial results and provide a corporate update.
VRNA Ratings Summary
VRNA Quant Ranking